Basel Medical Group (BMGL) is up 64.4% today. Here is some analysis on what might have caused this price movement.
Analysis: A clear company-specific catalyst for Monday, September 14, 2026 does not appear to be publicly disclosed. This could be because BMGL is a very thinly traded stock that has already shown a pattern of sharp percentage swings, with traders possibly reacting to its small float, recent corporate changes, and earlier signs of improving operating results rather than to fresh news. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2004489/000149315226041151/form6-k.htm?utm_source=openai))
Details:
Sources:
SEC, Nasdaq Trader, Stock Analysis
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$BMGL Hedge Fund Activity
We have seen 1 institutional investors add shares of $BMGL stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GROUND SWELL CAPITAL, LLC removed 33,705 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $19,889
- JANE STREET GROUP, LLC removed 16,288 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $115,338
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 15,290 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $108,271
- T3 COMPANIES, LLC removed 15,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $104,250
- RENAISSANCE TECHNOLOGIES LLC removed 14,498 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,555
- UBS GROUP AG removed 12,561 shares (-96.2%) from their portfolio in Q2 2026, for an estimated $87,298
- XTX TOPCO LTD removed 2,146 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $14,914
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.